359828-70-9

Usage

Synthetic compound

Derived from butanoic acid and difluorophenyl 2-(2,6-difluorophenyl)butanoic acid is a man-made chemical that is created by combining butanoic acid and difluorophenyl.

Pharmaceutical research and drug development

Commonly used 2-(2,6-difluorophenyl)butanoic acid is frequently utilized in the field of pharmaceuticals to study and develop new drugs, as it possesses potential therapeutic properties.

Anti-inflammatory properties

Has the potential to reduce inflammation 2-(2,6-difluorophenyl)butanoic acid has been studied for its ability to alleviate inflammation, which is a key factor in many medical conditions.

Analgesic properties

Potential to relieve pain The compound has shown promise in managing pain, making it a valuable research target for the development of new pain-relief medications.

Treatment of various conditions

Including pain, inflammation, and autoimmune disorders 2-(2,6-difluorophenyl)butanoic acid's unique properties make it a promising candidate for treating a range of medical conditions, from pain and inflammation to autoimmune disorders.

Unique structure and properties

Valuable tool for scientists and researchers The specific structure and characteristics of 2-(2,6-difluorophenyl)butanoic acid make it an important compound for those working to develop improved medications for a variety of medical conditions.

Upstream product

• 85068-28-6 2,6-difluorophenylacetic acid 
• 75-03-6 ethyl iodide 

Downstream Products

• 958237-61-1 4-(2,6-dichlorophenyl)-2-methyl-3-oxo-hexanoic acid ethyl ester 
• 1320339-95-4 2-(sec-butylthio)-6-(1-(2,6-difluorophenyl)propyl)pyrimidin-4(3H)-one 
• 1320339-96-5 6-(1-(2,6-difluorophenyl)propyl)-5-methyl-2-(methylthio)pyrimidin-4(3H)-one 
• 359828-67-4 6-(1-(2,6-difluorophenyl)propyl)-2-(isopropylthio)-5-methylpyrimidin-4(3H)-one 
• 927827-72-3 2-(sec-butylthio)-6-(1-(2,6-difluorophenyl)propyl)-5-methylpyrimidin-4(3H)-one 
• 1320339-97-6 2-(cyclopentylthio)-6-(1-(2,6-difluorophenyl)propyl)-5-methylpyrimidin-4(3H)-one 
• 1320339-94-3 6-(1-(2,6-difluorophenyl)propyl)-2-(methylthio)pyrimidin-4(3H)-one 
• 1613669-28-5 6-[(2,6-difluorophenyl)propyl]-5-methyl-2-butylthiopyrimidin-4(3H)-one 
• 1613669-27-4 6-[(2,6-difluorophenyl)propyl]-5-methyl-2-propylthiopyrimidin-4(3H)-one 
• 359828-78-7 ethyl 4-(2,6-difluorophenyl)-3-oxohexanoate 

Relevant academic research and scientific papers

Exploring the role of 2-chloro-6-fluoro substitution in 2-alkylthio-6-benzyl-5-alkylpyrimidin-4(3 H)-ones: Effects in HIV-1-infected cells and in HIV-1 reverse transcriptase enzymes

A comparison of the effects of the 6-(2-chloro-6-fluorobenzyl)-2- (alkylthio)pyrimidin-4(3H)-ones (2-Cl-6-F-S-DABOs) 7-12 and the related 6-(2,6-difluorobenzyl) counterparts 13-15 in HIV-1 infected cells and in the HIV-1 reverse transcriptase (RT) assays

Modulation of cell differentiation, proliferation, and tumor growth by dihydrobenzyloxopyrimidine non-nucleoside reverse transcriptase inhibitors

A series of 5-alkyl-2-(alkylthio)-6-(1-(2,6-difluorophenyl)propyl)-3,4- dihydropyrimidin-4(3H)-one derivatives (3a-h) belonging to the F 2-DABOs class of non-nucleoside HIV-1 reverse transcriptase inhibitors (NNRTIs) are endowed with a strong a

Structure-based design, synthesis, and biological evaluation of conformationally restricted novel 2-alkylthio-6-[1-(2,6-difluorophenyl)alkyl]-3,4-dihydro-5-alkylpyrimidin-4 (3H)-ones as non-nucleoside inhibitors of HIV-1 reverse transcriptase

5-Alkyl-2-(alkylthio)-6-(2,6-difluorobenzyl)-3,4-dihydropyrimidin-4(3H)-ones (S-DABOs 2) have been recently described as a new class of human immunodeficiency virus type 1 (HIV-1) non-nucleoside reverse transcriptase (RT) inhibitors (NNRTIs) active at nan